Literature DB >> 26788901

Gender Dysphoria in Adults.

Kenneth J Zucker1, Anne A Lawrence2, Baudewijntje P C Kreukels3.   

Abstract

Gender dysphoria (GD), a term that denotes persistent discomfort with one's biologic sex or assigned gender, replaced the diagnosis of gender identity disorder in the Diagnostic and Statistical Manual of Mental Disorders in 2013. Subtypes of GD in adults, defined by sexual orientation and age of onset, have been described; these display different developmental trajectories and prognoses. Prevalence studies conclude that fewer than 1 in 10,000 adult natal males and 1 in 30,000 adult natal females experience GD, but such estimates vary widely. GD in adults is associated with an elevated prevalence of comorbid psychopathology, especially mood disorders, anxiety disorders, and suicidality. Causal mechanisms in GD are incompletely understood, but genetic, neurodevelopmental, and psychosocial factors probably all contribute. Treatment of GD in adults, although largely standardized, is likely to evolve in response to the increasing diversity of persons seeking treatment, demands for greater client autonomy, and improved understanding of the benefits and limitations of current treatment modalities.

Entities:  

Keywords:  causal mechanisms; gender dysphoria; gender identity disorder; transsexualism; treatment

Mesh:

Year:  2016        PMID: 26788901     DOI: 10.1146/annurev-clinpsy-021815-093034

Source DB:  PubMed          Journal:  Annu Rev Clin Psychol        ISSN: 1548-5943            Impact factor:   18.561


  29 in total

Review 1.  To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.

Authors:  Rosalia Costa; Polly Carmichael; Marco Colizzi
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

Review 2.  Issues in Working with Transgender Individuals Who Sexually Harm.

Authors:  Shan Jumper
Journal:  Curr Psychiatry Rep       Date:  2021-05-19       Impact factor: 5.285

3.  Parent reports of adolescents and young adults perceived to show signs of a rapid onset of gender dysphoria

Authors:  Lisa Littman
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

Review 4.  [Trans healthcare : Between depsychopathologization and a needs-based treatment of accompanying mental disorders].

Authors:  T O Nieder; A Güldenring; A Köhler; P Briken
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

5.  Stigmatization, Resilience, and Mental Health Among a Diverse Community Sample of Transgender and Gender Nonbinary Individuals in the U.S.

Authors:  Pablo K Valente; Eric W Schrimshaw; Curtis Dolezal; Allen J LeBlanc; Anneliese A Singh; Walter O Bockting
Journal:  Arch Sex Behav       Date:  2020-06-23

6.  Should chromosomal analysis be performed routinely during the baseline evaluation of the gender affirmation process? The outcomes of a large cohort of gender dysphoric individuals.

Authors:  Aysel Kalaycı Yigin; Şenol Turan; Mustafa Tarık Alay; Yasin Kavla; Öznur Demirel; Mehmet Seven
Journal:  Int J Impot Res       Date:  2022-05-17       Impact factor: 2.896

7.  Autism Spectrum Disorder and Gender Dysphoria/Incongruence. A systematic Literature Review and Meta-Analysis.

Authors:  Aimilia Kallitsounaki; David M Williams
Journal:  J Autism Dev Disord       Date:  2022-05-20

8.  2D:4D Digit Ratios in Adults with Gender Dysphoria: A Comparison to Their Unaffected Same-Sex Heterosexual Siblings, Cisgender Heterosexual Men, and Cisgender Heterosexual Women.

Authors:  Şenol Turan; Murat Boysan; Mahmut Cem Tarakçıoğlu; Tarık Sağlam; Ahmet Yassa; Hasan Bakay; Ömer Faruk Demirel; Musa Tosun
Journal:  Arch Sex Behav       Date:  2021-03-10

9.  Self-Reported Changes in Attractions and Social Determinants of Mental Health in Transgender Adults.

Authors:  Sabra L Katz-Wise; Sari L Reisner; Jaclyn M White Hughto; Stephanie L Budge
Journal:  Arch Sex Behav       Date:  2016-08-19

10.  Cortical Gyrification in Transgender Individuals.

Authors:  Yanlu Wang; Behzad S Khorashad; Jamie D Feusner; Ivanka Savic
Journal:  Cereb Cortex       Date:  2021-06-10       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.